期刊文献+

NAAG肽酶基因剔除小鼠模型的建立及鉴定 被引量:4

Generation and confirmation of NAAG peptidase gene knockout mouse model
下载PDF
导出
摘要 目的建立N-乙酰天冬氨酰谷氨酸(NAAG)肽酶基因剔除小鼠模型,为在体研究NAAG肽酶基因的生物学功能并揭示其在脑损伤后继发性脑损害进程中的所起的作用创造条件。方法根据小鼠NAAG肽酶基因组的序列,设计基因剔除策略,构建基因剔除载体NAAG-KO-pBR322,以电穿孔方法将基因剔除载体导入胚胎干细胞(ES),应用G418和更昔洛韦进行正负筛选,获得双抗性克隆,聚合酶链式反应(PCR)鉴定并测序获得正确同源重组的ES细胞克隆。结果同源重组的ES细胞注入小鼠囊胚后获得11只嵌合率>50%嵌合体雄性小鼠,嵌合体小鼠与C57 BL/6J雌鼠交配后获得11只杂合子小鼠,其中雄性7只,雌性4只。在雌、雄杂合子小鼠交配的后代中获得7只纯合子小鼠,PCR鉴定其基因型,逆转录PCR(RT-PCR)提示该基因鼠未表达NAAG肽酶。结论我们成功建立了NAAG肽酶基因剔除小鼠模型,其中纯合子小鼠未出现胚胎致死现象;初步的表型观察未发现NAAG肽酶基因剔除小鼠出现异常改变。 Objective To establish N-acetylaspartylglutamate (NAAG) peptidase gene knockout mouse model and to create the condition for further in vivo study of its biological function and its role in the secondary brain damage after brain injury. Methods According to the NAAG peptidase genomic DNA sequence,the strategy of gene targeting was established, and the gene knockout vector (NAAG-KO-pBR322) was constructed. Electroporation of embryonic stem (ES) cells with the gene knockout vector and screening of both G418 and Ganciclovir resistant clones were performed. The homologous recombined ES cell clones were identified by polymerase chain reaction (PCR).Results After transplantation of homologous recombined ES cells into blastocysts through microinjection, there were 11 male chimeras born with embedment rate 〉50%. The male chimeras then were bred with C57BL/6J female mice and 7 (♂) and 4 (♀) offsprings with heterozygous genotype were acquired. Some heterozygote mice were intercrossed to generate mutant homozygotes. Finally, 7 mutant homozygote mice were obtained, whose genotype was identified by PCR. Reverse transcription PCR (RT-PCR) suggested that the NAAG peptidase gene was not expressed. Conclusion The NAAG peptidase gene knockout mice has been successfully established. The embryonic lethality in homologous mutant mice does not occur, and no abnormal change is found by preliminary observation of phenotype for NAAG peptidase gene knockout mice.
出处 《中华神经外科疾病研究杂志》 CAS 2012年第3期221-226,共6页 Chinese Journal of Neurosurgical Disease Research
基金 国家自然科学基金资助项目(30670719 81070990) 上海市科委基金资助项目(10QH1401700) 上海市级医院临床科研资源平台共享基金资助项目(SHDC12007708)
关键词 N-乙酰天冬氨酰谷氨酸 NAAG肽酶基因 基因剔除 脑损伤 N-acetylaspartylglutamate (NAAG) NAAG peptidase Gene knockout Brain injury
  • 相关文献

参考文献12

  • 1Tsukamoto T, Wozniak KM, Slusher BS. Progress in the discovery and develop-ment of glutamate carboxypeptidase II inhibitors [ J ]. Drug Discov Today, 2007, 12(17- 18): 767-776.
  • 2钟春龙,江基尧,罗其中,赵学仁,Bruce G.Lyeth.脑损伤后N-乙酰天冬氨酰谷氨酸肽酶抑制的神经保护[J].中华神经外科杂志,2009,25(10):937-940. 被引量:8
  • 3Zhong C, Zhao X, Sarva J, et al. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats [J]. J Neurotrauma, 2005, 22(2) : 266 -276.
  • 4Zhong C, Zhao X, Van KC, et al. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat [ J]. J Neurochem, 2006, 97(4) : 1015 -1025.
  • 5Chan W, Costantino N, Li R, et al. A recombineering based approach for high-throughput conditional knockout targeting vector construction [J]. Nucleic Acids Res, 2007, 35(8) : e64.
  • 6Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering- based method for generating conditional knockout mutations [ J ]. Genome Res, 2003, 13 (3):476-484.
  • 7Watt F, Martorana A, Brookes DE, et al. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1 [ J]. Genomics, 2011,73(3) : 243 -254.
  • 8Neale JH, 01szewski RT, Zuo D, et al. Advances in understanding the peptide NAAG and appearance of a new member of the NAAG neuropeptide family [ J ]. J Neurochem, 2011, 118 (4) : 489 - 490.
  • 9Chaux A, Eifler J, Karram S, et al. Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle : Implications for novel intraoperativc PSMA-based fluorescent imaging techniques [J]. Uro 0ncol, 2011, doi : 10. lO16/j, urolone. 2011.04. 002.
  • 10Shafizadeh TB, Halsted CH. Gamma-Glutamyl hydrolase, not glutamate carboxypeptidase II, hydrolyzes dietary folate in rat small intestine [J]. J Nutr, 2007, 137(5): 1149-1153.

二级参考文献10

  • 1江基尧.脑保护药物治疗颅脑损伤的现状与展望[J].中华创伤杂志,2006,22(4):241-242. 被引量:14
  • 2江基尧,钟春龙.神经递质受体与颅脑外伤.见:江基尧,朱诚,罗其中,主编.现代颅脑损伤学.第2版.上海:第二军医大学出版礼,2005:451-466.
  • 3Neale JH,Olszewski RT,Gehl LM,et al.The neurotransmitter N-acetylaspartylglutamate in models of pain,ALS,diabetic neuropathy.CNS injury and schizophrenia.Trends Pharmacol Sci,2005,26:477-484.
  • 4Kozikowski AP,Zhang J,Nan F,et al.Synthesis of ureabas-ed inhihitors as active site probes of glutamate carboxypeptidase Ⅱ:efficacy as analgesic agents.J Med Chem,2004,47:1729-1738.
  • 5Narayan RK,Michel ME,Ansell B,et al.Clinical trails in head injury.J Neurotrauma,2002,19:503-557.
  • 6Zhong C,Zhao X,Sarva J,et al.NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats.J Neurotrauma,2005,22:266-276.
  • 7Zhong C,Zhao X,Van KC,et al.NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate,aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.J Neurochem,2006,97:1015-1025.
  • 8Zhou J,Neale JH,Pomper MG,et al.NAAG peptidase inhibitors and their potential for diagnosis and therapy.Nature Reviews Drug Discovery,2005,4:1015-1026.
  • 9Zhao X,Ahram A,Muizelaar JP,et al.Early loss of astrocytes after experimental traumatic brain injury.Glia,2003,44:140-152.
  • 10Baslow MH.The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target.Drug News Perspect,2008,21:251-257.

共引文献7

同被引文献72

  • 1江基尧,钟春龙.神经递质受体与颅脑外伤.见:江基尧,朱诚,罗其中,主编.现代颅脑损伤学.第2版.上海:第二军医大学出版礼,2005:451-466.
  • 2Neale JH, Olszewski RT, Zuo D, et al. Advances in understanding the peptide NAAG and appearance of a new member of the NAAG neuropeptide family [J]. J Neurochem, 2011, 118(4) : 490 -498.
  • 3Arun P, Madhavarao CN, Moffett JR, et al. Regulation of N- acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activators [ J ]. J Neurochem, 2006, 98 (6) : 2034 -2042.
  • 4Tsukamoto T, Wozniak KM, Slusher BS. Progress in the discovery and development of glutamate carboxypeptidase II inhibitors [ J ]. Drug Diseov Today, 2007, 12(17 -18) : 767 -776.
  • 5Neale JH, Olszewski RT, Gehl LM, et al. The neurotransmitter N- acetylaspartyl- glutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia [ J ]. Trends Pharmacol Sci, 2005, 26 (9) : 477 - 484.
  • 6江基尧,钟春龙.神经递质受体与颅脑外伤[A].见:江基尧,朱诚,罗其中,主编.现代颅脑损伤学[M].第2版.上海:第二军医大学出版社,2005:451-466.
  • 7Zhong C, Zhao X, Sarva J, et al. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats [ J ]. J Neurotrauma, 2005,22 (2) : 266 - 276.
  • 8Zhong C, Zhao X, Van KC, et al. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat [ J ]. J Neurochem, 2006, 97(4): 1015-1025.
  • 9Feng JF, Van KC, Gurkoff GG, et al. Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI [J]. Brain Res, 2011, 1395:62-73.
  • 10Muir KW, Grosset DG. Neuroprotection for acute stroke: making clinical trials work [J]. Stroke, 1999, 30( 1 ) : 180 - 182.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部